JOIN4ATMP

Today, JOIN4ATMP coordinator Annette Künkele, from Charité - Universitätsmedizin Berlin presents the JOIN4ATMP project at the ESCGT 2024 and explains its mission and concrete objectives, in Rome.   🚀 This is the perfect occasion to launch our new series about our partners. Ever wondered who were the individuals carrying the JOIN4ATMP and contributing to an improved ATMP landscape in the EU?   📺 Watch the video to get to know Annette and discover the stakes of the JOIN4ATMP project.   Read more about CHARITE's tasks within the project on our website: https://lnkd.in/endw_J3h

Event update: JOIN4ATMP partners at the ESGCT 2024 🌟   📍 Rome, Italy 📅 Thursday October 24th   A busy week for the JOIN4ATMP consortium! In parallel of the WODC 2024, JOIN4ATMP partners Universitätsklinikum Würzburg, Vall d'Hebron Institute of Oncology (VHIO), Libera Università Vita-Salute San Raffaele and Fondazione Telethon, Charité - Universitätsmedizin Berlin will attend the prestigious European Society of Gene and Cell Therapy (ESGCT), starting today. Every year, this event brings together experts in the field to discuss the latest advances.   💬 On Thursday October 24th, JOIN4ATMP and T2EVOLVE consortia will hold a roundtable discussion: “T2EVOLVE/JOIN4ATMP Roundtable Discussion: Accelerating Cell and Gene Therapy development through Extrapolation and Platform Approaches”. The session, led by UKW, will showcase two real case examples on parent-child platform for CAR-T cell therapies targeting solid tumors, and platform approach for ex-vivo gene therapies for lysosomal storage disorders presented by our partners VHIO and Fondazione Telethon. 🎤 JOIN4ATMP coordinator Annette Künkele-Langer from Charité - Universitätsmedizin Berlin will also be present at the event to introduce the JOIN4ATMP project and explain its mission and concrete objectives.   🖼 JOIN4ATMP partner Mario Barilani, from Fondazione Telethon, will present the JOIN4ATMP project via the poster: “JOIN4ATMP Consortium: New frameworks for value assessment, pricing and reimbursement schemes of Advanced Therapy Medicinal Products”.   Learn more about the event in our article: https://lnkd.in/egdiUh55

Event update: JOIN4ATMP partners at the WODC 2024 🌟   📍 Barcelona, Spain 📅 Friday October 25th, 1.30pm   The World Orphan Drug Congress (WODC) is the largest global event focused on orphan drugs and rare diseases. For the occasion, JOIN4ATMP partner Vall d'Hebron Institute of Oncology (VHIO) and KU Leuven will participate in the session “Join together to optimize ATMP development pathways in the EU”, led by EURORDIS-Rare Diseases Europe.   This session will focus on the threats and opportunities in the development of new development pathways for ATMPs in Europe, and how they can address current gaps in healthcare for rare diseases. The JOIN4ATMP project will be showcased for capacity to answer to these needs and gather relevant actors around ATMP development.   🖼 JOIN4ATMP partner Erica di Pasquale, from Fondazione Telethon, will also shed a light on the matter and present a poster highlighting the needs and opportunities of ATMP development in Europe, with a focus on rare genetic diseases.   Learn more about the event in our article: https://lnkd.in/esZpYUdg

🌍 World Patient Safety Day 2024   Today, we highlight the critical importance of patient safety and the urgent need to enhance diagnostic processes.   Aligned with this mission, JOIN4ATMP is committed to expanding access to Advanced Therapy Medicinal Products (ATMPs) across the EU. Our global effort, supported by a diverse network of partners and stakeholders, aims to accelerate ATMP development by formulating actionable recommendations and solutions.   Discover more about the Patient Safety Day at: https://lnkd.in/gEmXAhKf

🔬🌍 Our European dimension   The JOIN4ATMP project embodies a European dimension and relies on a global vision of the challenges and opportunities shaping ATMP development in Europe. To this end, the project can count on the multi-disciplinarity of its partners and the expertise of the institutions it involves. By leveraging the collective strengths of our 14 partners around 9 European countries, the project paves the way for cutting-edge therapies that will boost ATMP innovation and health access across the EU territory.   🚨 Coming soon Get to know the individuals carrying the project in our upcoming video series introducing you to the bright minds from every institution of the JOIN4ATMP!   Already curious to know our partners? Discover our Partners Map here: https://lnkd.in/evdxXFSU   #ATMP #GeneTherapy #CellTherapy #EUScience #HealthcareInnovation #RegulatoryAffairs

📢 Exciting news! 🌟   Our partner EURORDIS-Rare Diseases Europe just launched their Rare Barometer survey! This questionnaire highlights at a European scale the experience and challenges that families and individuals living with rare diseases face daily. Individuals with rare diseases face persistent barriers in various aspects of their lives that often lead to unequal treatment and a lack of recognition for their conditions and disabilities.    📋 Contribute to the survey and #MakeYourVoiceHeard: tiny.cc/RB_DailyLife_Info   👥 Who can participate? The survey is open to participation to all people living with a rare disease and their close family members until 8th September 2024, and is available in 25 languages. Results of the survey will be published Eurordis' website by the end of the end of year.   👨👩👦 Are you a patient organisation and do you want to spread the word in your network? Eurordis has also published an actionable communication toolkit to disseminate survey in patient communities: https://lnkd.in/euRCBcYV    #RareBarometer #EURORDIS #rarediseases

📢 We are hiring - Postdoc alert!   Ready to take on a new challenge in the field of ATMPs? Our fellow partner Erasmus MC is opening two new exciting postdoctoral positions. If you are passionate about revolutionizing healthcare and eager to contribute to groundbreaking innovations, we want to hear from you!   👉 Coordinator of T cell ATMP manufacturing 👉 Harmonising the manufacture of ATMPs within Europe   Click the link below to learn more and apply today, or share it with someone who might be interested!   🔗 https://lnkd.in/dzqDJ3AY   #JOIN4ATMP #CareerOpportunity #ATMPs #JoinOurTeam #Postdoc #Opportunity

400 followers! 🥳 Thank you for being already 400 to follow us and be part of our ambitious journey! Together, let's grow our network of influence and bring efficient solutions to strengthen ATMP development in the EU! #JOIN4ATMP #ATMPs #Healthcare #GeneTherapy #CellTherapy #EUHealthcare

JOIN4ATMP is a project aiming to accelerate and de-risk the creation of Advanced Medicinal Therapies (ATMPs) in Europe. It aims to ensure wide-spread access of ATMPs through using of real-world data solutions to define new paths forward. But what are ATMPs? Through seven questions this article explains the basic tenants of this innovative type of medicine through seven easy questions & answers. 📖 Read now: https://lnkd.in/ezgm7RtA #Europe #project #RareDiseases #therapies #data #research

Are you new to Advanced Therapy Medicinal Products (ATMPs) or are you just looking to deepen your knowledge? 🧬✨ Dive into our latest article that answers 7 key questions to give you a clear understanding of this innovative field within the European context.   👓 Read the article now: https://lnkd.in/e4tMrrVw   #JOIN4ATMP #ATMPs #Healthcare #GeneTherapy #CellTherapy #EUHealthcare #Learning